Long-Acting Heterodimeric Paclitaxel–Idebenone Prodrug-Based Nanomedicine Promotes Functional Recovery after Spinal Cord Injury
Nano Letters · 20.03.2024 · 24 (11) · 3548-3556
DOI: 10.1021/acs.nanolett.4c00856 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 08.03.2024. Verfasst von Zunkai Xu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Functional Polymer Materials of Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center…. Hauptthemen laut MEDLINE: Axons, Spinal Cord Injuries. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Natural Science Foundation of Tianjin Municipality, National Natural Science Foundation of China, Nankai University Eye Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Functional Polymer Materials of Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tian…
- Tianjin Key Laboratory of Spine and Spinal Cord, International Science and Technology Cooperation Base of Spinal Cord Injury, Department of Orthopedics, International Chinese Musculoskeletal Research Society Collaborati…
- Center of Medical and Health Analysis, Peking University Health Science Center, Beijing 100191, China.
- Orthopedic Research Center of Shandong University and Department of Orthopedics, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
ORCID-Profile: Guangzhi Ning, Shutao Guo
Förderung
- Natural Science Foundation of Tianjin Municipality
- National Natural Science Foundation of China
- Nankai University Eye Institute
- Beijing-Tianjin-Hebei Basic Research Cooperation Project
Zitieren
APA
Xu, Z., Liu, X., Pang, Y., Chen, Z., Jiang, Y., Liu, T., Zhang, J., Xiong, H., Gao, X., Liu, J., Liu, S., Ning, G., Feng, S., Yao, X., & Guo, S. (2024). Long-Acting Heterodimeric Paclitaxel–Idebenone Prodrug-Based Nanomedicine Promotes Functional Recovery after Spinal Cord Injury. Nano Letters, 24(11), 3548-3556. https://doi.org/10.1021/acs.nanolett.4c00856
Vancouver
Xu Z, Liu X, Pang Y, Chen Z, Jiang Y, Liu T, et al. Long-Acting Heterodimeric Paclitaxel–Idebenone Prodrug-Based Nanomedicine Promotes Functional Recovery after Spinal Cord Injury. Nano Letters. 2024;24(11):3548-3556. doi:10.1021/acs.nanolett.4c00856
BibTeX
@article{Xu2024,
author = {Xu, Zunkai and Liu, Xinjie and Pang, Yilin and Chen, Zhixia and Jiang, Yaoyao and Liu, Tao and Zhang, Jiawei and Xiong, Haoning and Gao, Xiang and Liu, Jiao and Liu, Shen and Ning, Guangzhi and Feng, Shiqing and Yao, Xue and Guo, Shutao},
title = {Long-Acting Heterodimeric Paclitaxel–Idebenone Prodrug-Based Nanomedicine Promotes Functional Recovery after Spinal Cord Injury},
journal = {Nano Letters},
year = {2024},
volume = {24},
number = {11},
pages = {3548--3556},
doi = {10.1021/acs.nanolett.4c00856}
}
EUVIMED